Author:
Peres-da-Silva Allan,de Almeida Adilson José,Lampe Elisabeth
Publisher
Springer Science and Business Media LLC
Subject
Virology,General Medicine
Reference26 articles.
1. Asselah T, Benhamou Y, Marcellin P (2009) Protease and polymerase inhibitors for the treatment of hepatitis C. Liver Int 29:57–67. doi: 10.1111/j.1478-3231.2008.01928.x
2. Barbato G, Cicero DO, Nardi MC, Steinkühler C, Cortese R, De Francesco R et al (1999) The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism. J Mol Biol 289:371–384. doi: 10.1006/jmbi.1999.2745
3. Bartels DJ, Zhou Y, Zhang EZ, Marcial M, Byrn RA, Pfeiffer T et al (2008) Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects. J Infect Dis 198:800–807. doi: 10.1086/591141
4. Beyer BM, Zhang R, Hong Z, Madison V, Malcolm BA (2001) Effect of naturally occurring active site mutations on hepatitis C virus NS3 protease specificity. Proteins 43:82–88. doi: 10.1002/1097-0134(20010501)43:2<82::AID-PROT1020>3.0.CO;2-4
5. Campiotto S, Pinho JR, Carrilho FJ, Da Silva LC, Souto FJ, Spinelli V et al (2006) Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 39:41–49. doi: 10.1590/S0100-879X2005000100007
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献